AU2021349249A1 - Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals - Google Patents

Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals Download PDF

Info

Publication number
AU2021349249A1
AU2021349249A1 AU2021349249A AU2021349249A AU2021349249A1 AU 2021349249 A1 AU2021349249 A1 AU 2021349249A1 AU 2021349249 A AU2021349249 A AU 2021349249A AU 2021349249 A AU2021349249 A AU 2021349249A AU 2021349249 A1 AU2021349249 A1 AU 2021349249A1
Authority
AU
Australia
Prior art keywords
compound
substituted
alkyl
unsubstituted
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021349249A
Other languages
English (en)
Inventor
Jason Burch
Stéphane DORICH
Lee Fader
Miguel St-Onge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventus Therapeutics US Inc
Original Assignee
Ventus Therapeutics US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventus Therapeutics US Inc filed Critical Ventus Therapeutics US Inc
Publication of AU2021349249A1 publication Critical patent/AU2021349249A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2021349249A 2020-09-24 2021-09-23 Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals Abandoned AU2021349249A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063082695P 2020-09-24 2020-09-24
US63/082,695 2020-09-24
PCT/US2021/051670 WO2022066851A1 (en) 2020-09-24 2021-09-23 PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

Publications (1)

Publication Number Publication Date
AU2021349249A1 true AU2021349249A1 (en) 2023-04-13

Family

ID=80846865

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021349249A Abandoned AU2021349249A1 (en) 2020-09-24 2021-09-23 Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals

Country Status (7)

Country Link
US (1) US20240018138A1 (cg-RX-API-DMAC7.html)
EP (1) EP4216940A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023543254A (cg-RX-API-DMAC7.html)
CN (1) CN116209442A (cg-RX-API-DMAC7.html)
AU (1) AU2021349249A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196153A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022066851A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230124665A (ko) 2020-12-22 2023-08-25 노파르티스 아게 Cgas 관련 병태의 치료에 유용한 인돌 유도체
WO2023183275A1 (en) * 2022-03-22 2023-09-28 Ventus Therapeutics U.S., Inc. Hexahydropyrido[4,3-b]indolyl ketone derivatives useful as cgas modulators
CN121248633A (zh) * 2022-11-09 2026-01-02 勃林格殷格翰国际有限公司 作为cGAS抑制剂的环状苯并咪唑衍生物
CN120769854A (zh) * 2022-12-21 2025-10-10 伊莱利利公司 氮杂䓬并[4,5-B]吲哚酮cGAS抑制剂
AR133584A1 (es) 2023-08-18 2025-10-15 Univ Leuven Kath Nuevos compuestos
CN119490508A (zh) * 2023-08-21 2025-02-21 上海交通大学 一类螺环四氢-γ-咔啉衍生物的制备方法以及应用
WO2025218659A1 (en) * 2024-04-16 2025-10-23 Insilico Medicine Ip Limited Novel compounds as cyclic gmp-amp synthase inhibitor and uses thereof
WO2026026969A1 (zh) * 2024-08-01 2026-02-05 杭州英创医药科技有限公司 作为cGAS抑制剂的化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011019417A1 (en) * 2009-04-29 2011-02-17 Medivation Technologies, Inc. Pyrido [4, 3-b] indoles and methods of use
CN109311876B (zh) * 2016-06-16 2022-05-03 豪夫迈·罗氏有限公司 杂芳基雌激素受体调节剂及其用途
JP2021506862A (ja) * 2017-12-19 2021-02-22 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Tlr7/8アンタゴニストおよびそれらの使用
MX2020008237A (es) * 2018-02-05 2020-09-25 Univ Rockefeller Inhibidores de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol de cgas para tratar enfermedades autoinflamatorias.
WO2020142729A1 (en) * 2019-01-04 2020-07-09 BellBrook Labs Inhibitors of cgas activity as therapeutic agents
WO2020186027A1 (en) * 2019-03-13 2020-09-17 Daisuke Tomita Inhibitors of cgas for treating autoinflammatory diseases and cancer metastasis

Also Published As

Publication number Publication date
JP2023543254A (ja) 2023-10-13
US20240018138A1 (en) 2024-01-18
WO2022066851A1 (en) 2022-03-31
EP4216940A1 (en) 2023-08-02
CA3196153A1 (en) 2022-03-31
EP4216940A4 (en) 2025-01-01
CN116209442A (zh) 2023-06-02

Similar Documents

Publication Publication Date Title
WO2022066851A1 (en) PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
CN113286794B (zh) Kras突变蛋白抑制剂
CA3124898C (en) Heterocyclic compound, intermediate, preparation method therefor and application thereof
CN1143080A (zh) 7-二环取代的-3-喹喏酮羧酸衍生物的制备方法
EP3684776A1 (en) Heterocyclyl substituted pyrrolopyridines that are inhibitors of the cdk12 kinase
CN111171049B (zh) 酪氨酸激酶抑制剂及其用途
CN115232129A (zh) 一种parp1选择性抑制剂及其制备方法和用途
CN120659784A (zh) 作为c-Kit激酶抑制剂的化合物和组合物
CN107205972A (zh) 自分泌运动因子的取代的n‑(2‑(氨基)‑2‑氧代乙基)苯甲酰胺抑制剂及它们的制备和在治疗lpa‑依赖的或lpa‑介导的疾病中的用途
TWI762534B (zh) 作為PI3Kδ抑制劑的咪唑並[1,5-A]吡衍生物
WO2014151630A2 (en) Compounds and compositions for the treatment of parasitic diseases
JP2020506878A (ja) Trek(twik関連kチャネル)チャネルのアクチベータ
US11858938B2 (en) Imidazo-fused heterocycles and uses thereof
CN114667289B (zh) 杂芳基血浆激肽释放酶抑制剂
CN111704615B (zh) 咪唑并[1,5-A]吡嗪衍生物作为PI3Kδ抑制剂
WO2023143249A1 (zh) 靶向malt1的蛋白降解化合物
WO2013021051A1 (en) Antibacterial homopiperidinyl substituted 3,4 dihydro 1h [1,8]naphthyridinones
KR20240121746A (ko) 테트라하이드로피리다진, 이를 포함하는 조성물, 및 이의 용도
CN121399103A (zh) 一类细胞程序性坏死抑制剂及其制备方法和用途
CN115697972A (zh) 包括哌嗪杂环酰胺脲的受体-相互作用蛋白1抑制剂
CN115066423B (zh) Pd-l1拮抗剂化合物
CN112778273B (zh) 环酮并吡啶酮类化合物及其制备方法和用途
CN119661531A (zh) 咪唑酮类化合物及其制备方法和应用
CN112409361B (zh) Tam抑制剂及其用途
HK40093069A (en) Pyrido[4,3-b]indole derivatives and their use as pharmaceuticals

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period